echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J Clin Rheumatol: No significant difference in the risk of serious infections in rheumatoid arthritis with different JAK inhibitors

    J Clin Rheumatol: No significant difference in the risk of serious infections in rheumatoid arthritis with different JAK inhibitors

    • Last Update: 2022-05-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    JAKs kinases are cytoplasmic tyrosine kinases associated with membrane cytokine receptors, which mediate the signaling of various cytokines and growth factors, and are involved in the pathogenesis of various autoimmune diseases


    Researchers searched PubMed, EMBASE, the Cochrane Library and clinicaltrials.


     

    RESULTS: A total of 37 randomized controlled trials were included in the study


    Taken together, the findings suggest that rheumatoid arthritis patients have a similar risk of developing serious infections among currently approved JAK inhibitor drugs


     

    Original source:

     

    Carlos Alves, et al.




    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.